Evidence map›Paper›PMID 20107229›Full record

ArticleBlood2010

Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis.

Julia A Brown, Kristen Stevenson, Haesook T Kim, Corey Cutler, Karen Ballen, Sean McDonough, Carol Reynolds, Maria Herrera, Deborah Liney, Vincent Ho and 12 more

Registry-linked trialAbstract read
In one paragraph

Article in Blood, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00133367 (Phase II Study of Sequential Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus as Graft Versus Host Disease Prophylaxis), which is not on this map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00133367 phase2completednot on this map

Phase II Study of Sequential Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus as Graft Versus Host Disease Prophylaxis

TypeinterventionalSponsorMassachusetts General HospitalRan2005 to 2011Enrolled32ConditionsMultiple Myeloma, Non-Hodgkin's Lymphoma, Hodgkin's Disease, Myelogenous LeukemiaArmsTacrolimus, Sirolimus, G-CSF, Antithymocyte globulin, Thymoglobulin
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 97 citations in OpenAlex.

  1. Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2017
    Trial
  2. Trial
  3. Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2012
    Trial
  4. Trial
  5. Review
  6. Review
  7. Review
  8. A Simple-to-PerformFrontiers in immunology · 2022
    Article
  9. Article
  10. Unlicensed Umbilical Cord Blood Units Provide a Safe and Effective Graft Source for a Diverse Population: A Study of 2456 Umbilical Cord Blood Recipients.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Immune Reconstitution Disorders: Spotlight on Interferons.International journal of biomedical investigation · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 1 country.

Julia A BrownDepartment of Medicine, Division of Hematology/Oncology and Cancer Biology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Kristen Stevenson
Haesook T Kim
Corey Cutler
Karen Ballen
Sean McDonough
Carol Reynolds
Maria Herrera
Deborah Liney
Vincent Ho
Grace Kao
Philippe Armand
John Koreth
Edwin Alyea
Steve McAfee
Eyal Attar
Bimalangshu Dey
Thomas Spitzer
Robert Soiffer
Jerome Ritz
Joseph H Antin
Vassiliki A Boussiotis
Dana-Farber Cancer Institute · USMassachusetts General Hospital · USBeth Israel Deaconess Medical Center · US

Funding

Project 3: Humoral Targets and B Cell Biology in Chronic Graft-vs.-Host DiseaseP01CA142106 · NCI · DANA-FARBER CANCER INST · PI CUTLER, COREY S · 2009 to 2019
$17.5M
Reconstitution of Regulatory T Cells after Allogeneic Stem Cell TransplantationU19AI029530 · NIAID · DANA-FARBER CANCER INSTITUTE · PI SOIFFER, ROBERT JON · 2005 to 2010
$9.0M
T CELL NEOGENESIS AFTER STEM CELL TRANSPLANTATIONP01AI029530 · NIAID · DANA-FARBER CANCER INSTITUTE · PI RITZ, JEROME · 1990 to 2003
$4.5M
TRAINING PROGRAM IN CANCER BIOLOGYT32CA081156 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BALK, STEVEN P. · 2000 to 2011
$2.9M
The Role of Rap1 in T-Cell ResponsesR01AI043552 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BOUSSIOTIS, VASSILIKI A · 1998 to 2009
$2.1M
Expression and Function of Tob in T LymphocytesR01CA104596 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BOUSSIOTIS, VASSILIKI A · 2005 to 2009
$1.6M
Reconstitution of T cell immunity after UCB transplantation: The role of TregR21CA123855 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BOUSSIOTIS, VASSILIKI A · 2008 to 2009
$783k
The role of Rap1 and its novel associated molecules in T cell responsesR56AI043552 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BOUSSIOTIS, VASSILIKI A · 2011 to 2011
$392k
The Role of Rap1 in T-Cell ResponsesR21AI043552 · NIAID · DANA-FARBER CANCER INSTITUTE · PI BOUSSIOTIS, VASSILIKI A · 2003 to 2003
$171k
NCI NIH HHS CA104596NCI NIH HHS CA123855NCI NIH HHS CA142106NCI NIH HHS P01 CA142106NCI NIH HHS R01 CA104596NCI NIH HHS R21 CA123855NCI NIH HHS T32 CA081156NCI NIH HHS T32CA081156NHLBI NIH HHS HL087870NIAID NIH HHS AI029530NIAID NIH HHS AI43552NIAID NIH HHS P01 AI029530NIAID NIH HHS R01 AI043552NIAID NIH HHS R21 AI043552NIAID NIH HHS R56 AI043552NIAID NIH HHS U19 AI029530
6 · The paper itself

Abstract

Umbilical cord blood grafts are increasingly used as sources of hematopoietic stem cells in adults. Data regarding the outcome of this approach in adults are consistent with delayed and insufficient immune reconstitution resulting in high infection-related morbidity and mortality. Using cytomegalovirus (CMV)-specific immunity as a paradigm, we evaluated the status, mechanism, and clinical implications of immune reconstitution in adults with hematologic malignancies undergoing unrelated double unit cord blood transplantation. Our data indicate that CD8(+) T cells capable of secreting interferon-gamma (IFN-gamma) in a CMV-specific enzyme-linked immunosorbent spot (ELISpot) assay are detectable at 8 weeks after transplantation, before reconstitution of thymopoiesis, but fail to clear CMV viremia. Clearance of CMV viremia occurs later and depends on the recovery of CD4(+)CD45RA(+) T cells, reconstitution of thymopoiesis, and attainment of T-cell receptor rearrangement excision circle (TREC) levels of 2000 or more copies/mug DNA. In addition, overall survival was significantly higher in patients who displayed thymic regeneration and attainment of TREC levels of 2000 or more copies/mug DNA (P = .005). These results indicate that reconstitution of thymopoiesis is critical for long-term clinical outcome in adult recipients of umbilical cord blood transplant. The trial was prospectively registered at http://www.clinicaltrials.gov (NCT00133367).

Indexed as

Cord Blood Stem Cell TransplantationFetal BloodAdultAgedCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCytomegalovirusCytomegalovirus InfectionsFemaleHumansImmunophenotypingInterferon-gammaLymphocytesMaleMiddle AgedMyeloid CellsInterferon-gammaReceptors, Antigen, T-Cell

Identifiers

PMID20107229
PMCPMC3372946
OpenAlexW2024859468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.